ProfileGDS4814 / ILMN_1751958
TitleOvarian cancer xenograft tumor response to trastuzumab and pertuzumab
OrganismHomo sapiens


none trastuzumab pertuzumab trastuzumab and pertuzumab GSM780707 GSM780708 GSM780709 GSM780719 GSM780720 GSM780721 GSM780710 GSM780711 GSM780712 GSM780722 GSM780723 GSM780724 GSM780713 GSM780714 GSM780715 GSM780725 GSM780726 GSM780727 GSM780716 GSM780717 GSM780718 GSM780728 GSM780729 84% 84% 84% 85% 86% 84% 84% 85% 83% 85% 86% 85% 84% 84% 85% 85% 83% 84% 86% 86% 86% 87% 85% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM780707Untreated after 4 days (C1_1)214.71684
GSM780708Untreated after 4 days (C2_1)206.36384
GSM780709Untreated after 4 days (C3_1)200.35284
GSM780719Untreated after 4 days (C1_2)239.30285
GSM780720Untreated after 4 days (C2_2)258.13286
GSM780721Untreated after 4 days (C3_2)217.97884
GSM780710Trastuzumab treated after 4 days (T1_1)213.18184
GSM780711Trastuzumab treated after 4 days (T2_1)221.01885
GSM780712Trastuzumab treated after 4 days (T3_1)198.32683
GSM780722Trastuzumab treated after 4 days (T1_2)225.47885
GSM780723Trastuzumab treated after 4 days (T2_2)247.96886
GSM780724Trastuzumab treated after 4 days (T3_2)227.43485
GSM780713Pertuzumab treated after 4 days (P1_1)203.71884
GSM780714Pertuzumab treated after 4 days (P2_1)203.30784
GSM780715Pertuzumab treated after 4 days (P3_1)229.54585
GSM780725Pertuzumab treated after 4 days (P1_2)242.04285
GSM780726Pertuzumab treated after 4 days (P2_2)188.15183
GSM780727Pertuzumab treated after 4 days (P3_2)203.23784
GSM780716Trastuzumab and Pertuzumab treated after 4 days (TP1_1)268.53286
GSM780717Trastuzumab and Pertuzumab treated after 4 days (TP2_1)268.30286
GSM780718Trastuzumab and Pertuzumab treated after 4 days (TP3_1)259.69186
GSM780728Trastuzumab and Pertuzumab treated after 4 days (TP1_2)271.22187
GSM780729Trastuzumab and Pertuzumab treated after 4 days (TP2_2)228.62885